Theratechnologies Historical Financial Ratios
| TH Stock | CAD 1.74 0.06 3.57% |
Theratechnologies is promptly reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 3.5 M, Stock Based Compensation To Revenue of 0.0272, Capex To Depreciation of 0.88 or Ev To Sales of 0.89 will help investors to properly organize and evaluate Theratechnologies financial condition quickly.
Theratechnologies |
About Theratechnologies Financial Ratios Analysis
TheratechnologiesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Theratechnologies investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Theratechnologies financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Theratechnologies history.
Theratechnologies Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Theratechnologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Theratechnologies sales, a figure that is much harder to manipulate than other Theratechnologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Theratechnologies' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Average Inventory is very stable compared to the past year. As of the 27th of November 2024, Cash Per Share is likely to grow to 1.85, while Price To Sales Ratio is likely to drop 0.56.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.04 | 2.81 | 2.53 | 2.65 | Days Of Inventory On Hand | 273.45 | 112.76 | 101.49 | 106.56 |
Theratechnologies fundamentals Correlations
Click cells to compare fundamentals
Theratechnologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Theratechnologies fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 10.75 | 17.42 | 10.39 | 0.51 | 0.59 | 0.56 | |
| Ptb Ratio | 220.17 | 68.49 | (36.84) | (2.0) | (1.8) | (1.71) | |
| Days Sales Outstanding | 60.49 | 48.41 | 48.6 | 57.13 | 65.7 | 62.42 | |
| Book Value Per Share | 0.0419 | 0.19 | (0.24) | (0.79) | (0.91) | (0.87) | |
| Free Cash Flow Yield | (0.0191) | (0.012) | (0.0189) | (0.18) | (0.21) | (0.2) | |
| Operating Cash Flow Per Share | (0.0441) | (0.18) | (0.16) | (0.15) | (0.22) | (0.19) | |
| Stock Based Compensation To Revenue | 0.0216 | 0.0277 | 0.0484 | 0.0244 | 0.028 | 0.0272 | |
| Capex To Depreciation | 0.003756 | 0.019 | 0.079 | 0.55 | 0.63 | 0.88 | |
| Pb Ratio | 220.17 | 68.49 | (36.84) | (2.0) | (1.8) | (1.71) | |
| Ev To Sales | 11.39 | 17.94 | 10.92 | 0.81 | 0.94 | 0.89 | |
| Free Cash Flow Per Share | (0.004919) | (0.0912) | (0.18) | (0.16) | (0.28) | (0.27) | |
| Roic | (0.14) | (0.32) | (0.35) | (0.95) | (0.29) | (0.26) | |
| Inventory Turnover | 1.07 | 0.8 | 1.33 | 3.24 | 2.91 | 3.06 | |
| Net Income Per Share | (0.29) | (0.34) | (0.5) | (0.91) | (1.05) | (0.99) | |
| Days Of Inventory On Hand | 341.16 | 457.29 | 273.45 | 112.76 | 101.49 | 106.56 | |
| Payables Turnover | 1.54 | 1.5 | 2.04 | 2.81 | 2.53 | 2.65 | |
| Research And Ddevelopement To Revenue | 0.27 | 0.4 | 0.46 | 0.37 | 0.43 | 0.41 | |
| Capex To Revenue | 4.84E-4 | 0.002377 | 0.0123 | 0.0222 | 0.0256 | 0.0243 | |
| Cash Per Share | 0.27 | 0.44 | 0.35 | 1.53 | 1.76 | 1.85 | |
| Pocfratio | (52.37) | (84.02) | (56.6) | (7.35) | (8.45) | (8.87) | |
| Interest Coverage | (3.35) | (4.46) | (6.14) | (1.01) | (1.16) | (1.1) | |
| Capex To Operating Cash Flow | (0.002361) | (0.0115) | (0.067) | (0.32) | (0.37) | (0.35) | |
| Pfcf Ratio | (52.25) | (83.06) | (53.04) | (5.57) | (6.4) | (6.72) | |
| Days Payables Outstanding | 237.57 | 243.64 | 178.98 | 129.94 | 116.94 | 122.79 | |
| Income Quality | 0.6 | 0.46 | 0.31 | 0.24 | 0.21 | 0.2 | |
| Roe | (7.03) | (1.79) | 2.09 | 1.15 | 1.32 | 1.39 | |
| Ev To Operating Cash Flow | (55.52) | (86.53) | (59.52) | (11.73) | (13.49) | (14.16) | |
| Pe Ratio | (31.32) | (38.34) | (17.6) | (1.74) | (1.57) | (1.49) | |
| Return On Tangible Assets | (0.0471) | (0.22) | (0.33) | (0.37) | (0.42) | (0.44) | |
| Ev To Free Cash Flow | (55.39) | (85.55) | (55.78) | (8.88) | (10.22) | (10.73) | |
| Earnings Yield | (0.0319) | (0.0261) | (0.0568) | (0.57) | (0.66) | (0.63) | |
| Net Debt To E B I T D A | (4.65) | (2.11) | (1.54) | (2.52) | (2.9) | (3.05) | |
| Current Ratio | 2.74 | 2.05 | 1.55 | 0.64 | 1.34 | 1.46 | |
| Tangible Book Value Per Share | (0.37) | (0.0657) | (0.39) | (1.27) | (1.46) | (1.38) | |
| Receivables Turnover | 6.03 | 7.54 | 7.51 | 6.39 | 5.75 | 5.69 | |
| Graham Number | 0.53 | 1.22 | 1.63 | 4.03 | 4.63 | 2.43 |
Pair Trading with Theratechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.
The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.